カテゴリ： GlobalData, 企業調査

Fujirebio Diagnostics Inc：企業の製品パイプライン分析

◆英語タイトル：Fujirebio Diagnostics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード：GDME2171PD
◆発行会社（調査会社）：GlobalData
◆発行日：2021年1月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：Medical Devices
◆販売価格オプション（消費税別）
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent controls, EIA kits, and other test kits, among others. Its serum products comprise enzyme conjugate stabilizer, glycated human hemoglobin animal serums, and nonglycated human haemoglobin, among others. FDI also provides reagents and controls, and manual assay products, among others. The company offers elisa antibody and antigen kits. It has its operations through its offices located in the US, Italy and Russia. FDI is headquartered in Malvern, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Fujirebio Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Fujirebio Diagnostics Inc Company Overview
Fujirebio Diagnostics Inc Company Snapshot
Fujirebio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Fujirebio Diagnostics Inc – Pipeline Analysis Overview
Fujirebio Diagnostics Inc – Key Facts
Fujirebio Diagnostics Inc – Major Products and Services
Fujirebio Diagnostics Inc Pipeline Products by Development Stage
Fujirebio Diagnostics Inc Pipeline Products Overview
Lumipulse G – ApoB48 Assay Kit
Lumipulse G – ApoB48 Assay Kit Product Overview
Lumipulse G – HAVAb Assay Kit
Lumipulse G – HAVAb Assay Kit Product Overview
Lumipulse G – HBsAb Assay Kit
Lumipulse G – HBsAb Assay Kit Product Overview
Lumipulse G – HBsAg-Qualitative Assay Kit
Lumipulse G – HBsAg-Qualitative Assay Kit Product Overview
Lumipulse G – HBsAg-Quant Confirmation Assay Kit
Lumipulse G – HBsAg-Quant Confirmation Assay Kit Product Overview
Lumipulse G – HCV Ab Assay Kit
Lumipulse G – HCV Ab Assay Kit Product Overview
Lumipulse G – HCV Ag Assay Kit
Lumipulse G – HCV Ag Assay Kit Product Overview
Lumipulse G – HIV 1/2 Assay Kit
Lumipulse G – HIV 1/2 Assay Kit Product Overview
Lumipulse G – HIV-1p24 Assay Kit
Lumipulse G – HIV-1p24 Assay Kit Product Overview
Lumipulse G – HIVAg/Ab Assay Kit
Lumipulse G – HIVAg/Ab Assay Kit Product Overview
Lumipulse G – HTLV-l Assay Kit
Lumipulse G – HTLV-l Assay Kit Product Overview
Lumipulse G – L- FABP Assay
Lumipulse G – L- FABP Assay Product Overview
Lumipulse G – NCC-ST439 Assay
Lumipulse G – NCC-ST439 Assay Product Overview
Lumipulse G – PLAP Assay Kit
Lumipulse G – PLAP Assay Kit Product Overview
Lumipulse G C-Peptide Assay Kit
Lumipulse G C-Peptide Assay Kit Product Overview
Lumipulse G Mesothelin Assay
Lumipulse G Mesothelin Assay Product Overview
Lumipulse G ß-Amyloid Ratio (1-42/1-40)
Lumipulse G ß-Amyloid Ratio (1-42/1-40) Product Overview
Lumipulse G1200 – AMH
Lumipulse G1200 – AMH Product Overview
Lumipulse G1200 – Estradiol Assay
Lumipulse G1200 – Estradiol Assay Product Overview
Lumipulse G1200 – pTAU
Lumipulse G1200 – pTAU Product Overview
Lumipulse G1200 – ß-amyloid 1-42
Lumipulse G1200 – ß-amyloid 1-42 Product Overview
Lumipulse G1200 – Total TAU
Lumipulse G1200 – Total TAU Product Overview
Lumipulse SARS CoV-2 Antigen Assay
Lumipulse SARS CoV-2 Antigen Assay Product Overview
Fujirebio Diagnostics Inc – Key Competitors
Fujirebio Diagnostics Inc – Key Employees
Fujirebio Diagnostics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Fujirebio Diagnostics Inc, Recent Developments
Jun 12, 2018: Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay
Apr 05, 2017: Fujirebio Europe Launches Lumipulse G HTLV-I/II for Fully Automated Screening of HTLV-I/II Viral Infection
Feb 19, 2016: Fujirebio Europe Launches Lumipulse G Mesothelin, The First Fully Automated Immunoassay to Aid in the Diagnosis of Malignant Mesothelioma
Jan 11, 2016: Fujirebio Europe launches Lumipulse G B•R•A•H•M•S PCT for fully automated testing on theLUMIPULSE G series
Jun 18, 2015: Fujirebio Europe Releases The Lumipulse G He4 Assay Dedicated To Ovarian Cancer Therapy Monitoring And Conservative Management Of Women With Pelvic Mass
Sep 06, 2011: Fujirebio Receives FDA 510 (k) Clearance For ROMA (HE4 EIA + ARCHITECT CA 125 II) Test To Monitor Ovarian Cancer
Jun 06, 2011: Fujirebio Reports New Publication Validates Use Of HE4 In Evaluating Risk Of Ovarian Cancer
May 31, 2011: Fujirebio Receives FDA 510 (k) Clearance For CYFRA 21-1 EIA Assay To Monitor Lung Cancer
Mar 23, 2009: Fujirebio Diagnostics Appoints Grady Barnes As CSO
Feb 11, 2009: Fujirebio Diagnostics` Risk Of Ovarian Malignancy Algorithm(ROMA) In Combination With Biomarker Demonstrates Accuracy In Detecting Ovarian Cancer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fujirebio Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Fujirebio Diagnostics Inc Pipeline Products by Equipment Type
Fujirebio Diagnostics Inc Pipeline Products by Indication
Fujirebio Diagnostics Inc, Key Facts
Fujirebio Diagnostics Inc, Major Products and Services
Fujirebio Diagnostics Inc Number of Pipeline Products by Development Stage
Fujirebio Diagnostics Inc Pipeline Products Summary by Development Stage
Lumipulse G - ApoB48 Assay Kit - Product Status
Lumipulse G - ApoB48 Assay Kit - Product Description
Lumipulse G - HAVAb Assay Kit - Product Status
Lumipulse G - HAVAb Assay Kit - Product Description
Lumipulse G - HBsAb Assay Kit - Product Status
Lumipulse G - HBsAb Assay Kit - Product Description
Lumipulse G - HBsAg-Qualitative Assay Kit - Product Status
Lumipulse G - HBsAg-Qualitative Assay Kit - Product Description
Lumipulse G - HBsAg-Quant Confirmation Assay Kit - Product Status
Lumipulse G - HBsAg-Quant Confirmation Assay Kit - Product Description
Lumipulse G - HCV Ab Assay Kit - Product Status
Lumipulse G - HCV Ab Assay Kit - Product Description
Lumipulse G - HCV Ag Assay Kit - Product Status
Lumipulse G - HCV Ag Assay Kit - Product Description
Lumipulse G - HIV 1/2 Assay Kit - Product Status
Lumipulse G - HIV 1/2 Assay Kit - Product Description
Lumipulse G - HIV-1p24 Assay Kit - Product Status
Lumipulse G - HIV-1p24 Assay Kit - Product Description
Lumipulse G - HIVAg/Ab Assay Kit - Product Status
Lumipulse G - HIVAg/Ab Assay Kit - Product Description
Lumipulse G - HTLV-l Assay Kit - Product Status
Lumipulse G - HTLV-l Assay Kit - Product Description
Lumipulse G - L- FABP Assay - Product Status
Lumipulse G - L- FABP Assay - Product Description
Lumipulse G - NCC-ST439 Assay - Product Status
Lumipulse G - NCC-ST439 Assay - Product Description
Lumipulse G - PLAP Assay Kit - Product Status
Lumipulse G - PLAP Assay Kit - Product Description
Lumipulse G C-Peptide Assay Kit - Product Status
Lumipulse G C-Peptide Assay Kit - Product Description
Lumipulse G Mesothelin Assay - Product Status
Lumipulse G Mesothelin Assay - Product Description
Lumipulse G ß-Amyloid Ratio (1-42/1-40) - Product Status
Lumipulse G ß-Amyloid Ratio (1-42/1-40) - Product Description
Lumipulse G1200 - AMH - Product Status
Lumipulse G1200 - AMH - Product Description
Lumipulse G1200 - Estradiol Assay - Product Status
Lumipulse G1200 - Estradiol Assay - Product Description
Lumipulse G1200 - pTAU - Product Status
Lumipulse G1200 - pTAU - Product Description
Lumipulse G1200 - ß-amyloid 1-42 - Product Status
Lumipulse G1200 - ß-amyloid 1-42 - Product Description
Lumipulse G1200 - Total TAU - Product Status
Lumipulse G1200 - Total TAU - Product Description
Lumipulse SARS CoV-2 Antigen Assay - Product Status
Lumipulse SARS CoV-2 Antigen Assay - Product Description
Fujirebio Diagnostics Inc, Key Employees
Fujirebio Diagnostics Inc, Subsidiaries
Glossary

★海外企業調査レポート[Fujirebio Diagnostics Inc：企業の製品パイプライン分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bartlett Holdings Inc：電力：M&Aディール及び事業提携情報
    Summary Bartlett Holdings Inc, doing business as BHI Energy, a subsidiary of AE Industrial Partners LLC, is a specialty service and staffing solutions provider. The company offers complete maintenance, radiological and professional technical staffing solutions. It provides power services including m …
  • Central Securities Corp (CET)：企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a investment management company. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, warrants, options real estate and …
  • Gran Tierra Energy Inc (GTE)：石油・ガス：M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • Chatham Lodging Trust：企業のM&A・事業提携・投資動向
    Chatham Lodging Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chatham Lodging Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Medytox Inc (086900)：企業の財務・戦略的SWOT分析
    Summary Medytox Inc (Medytox) develops, manufactures and markets biopharmaceutical products. Its products include botulinum toxin type A product, hyaluronic acid filler, medical devices, prescription cream, toxin detection kits and antitoxin therapeutics for treating skin disorders. The company is a …
  • Goodfellow Inc (GDL)：企業の財務・戦略的SWOT分析
    Goodfellow Inc (GDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • OBI Pharma Inc (4174)-医療機器分野：企業M&A・提携分析
    Summary OBI Pharma Inc (OBI Pharma) is a developer of therapies for the treatment of cancer and infectious diseases. The company develops its pipeline products through its carbohydrate synthesis discovery platform. Its flagship products include OBI-822, an active immunotherapy which is intended for …
  • Comet Ridge Ltd (COI)：石油・ガス：M&Aディール及び事業提携情報
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • Luxoft Holding Inc：企業の戦略・SWOT・財務情報
    Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report Summary Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aluminium Bahrain BSC (ALBH)：企業の財務・戦略的SWOT分析
    Aluminium Bahrain BSC (ALBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Miracor Medical Systems GmbH-医療機器分野：企業M&A・提携分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Royal Mail plc (RMG)：企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Beneo GmbH：企業の戦略・SWOT・財務情報
    Beneo GmbH - Strategy, SWOT and Corporate Finance Report Summary Beneo GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • BioMar Group AS：企業の戦略的SWOT分析
    BioMar Group AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • GenapSys Inc：医療機器：M&Aディール及び事業提携情報
    Summary GenapSys Inc (GenapSys) is engaged in the development of DNA sequencing technologies for applied genomic testing, and medical sequencing. The company offers a Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology platform that identifies the genome and delivers the insights of …
  • Schiller AG：企業の戦略的SWOT分析
    Schiller AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aesculap Inc-医療機器分野：企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • UbiQ Bio BV：製薬・医療：M&Aディール及び事業提携情報
    Summary UbiQ Bio BV (UbiQ) is a biotechnology company that develops and commercializes ubiquitinated peptides and assays that enables drug discovery in Ubiquitin field. The company provides products such as ubiquitin-proteasome system, high throughput screening assay reagents and ubiquitinated polyp …
  • Fusion Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Fusion Pharmaceuticals Inc (Fusion Pharmaceuticals) is a clinical-stage biopharmaceutical company which develops targeted alpha-particle radio therapeutics for the treatment of chemotherapy resistant cancers. Its pipeline product includes FPX-01, a radiolabeled antibody designed to internali …
  • Shionogi & Co Ltd (4507)：製薬・医療：M&Aディール及び事業提携情報
    Summary Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company's core pharmaceuticals product business offers drugs for the treatment of disorders in the areas of metabolism, infe …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆